ETFs DBV Technologies

DBV

FR0010417345

Pharmaceuticals

Market Closed - Euronext Paris 11:55:00 2026-10-16 EDT			5-day change	1st Jan Change
1.568 ^EUR	-3.39%		-6.56%	-53.61%

10-16	European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading	MT
10-13	European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading	MT

ETFs positioned on DBV Technologies

Name	YTD change	Weight	AuM
STATE STREET SPDR S&P INTERNATIONAL SMALL CAP ETF - USD	+9.45%	0.01%	918 M€
STATE STREET SPDR PORTFOLIO EUROPE ETF - USD	+3.49%	0%	742 M€
STATE STREET SPDR GLOBAL ALLOCATION ETF - DISTRIBUTING - USD	+6.03%	0%	317 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+12.25%	0%	62 M€

DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.

Employees

170

Sector

Pharmaceuticals

Calendar

10-27 Earnings release - Q3 2026

More about the company